PureTech’s deupirfenidone gets FDA and EC Orphan Drug Designations for idiopathic pulmonary fibrosis

PureTech’s deupirfenidone gets FDA and EC Orphan Drug Designations for idiopathic pulmonary fibrosis

PureTech Health’s deupirfenidone (LYT-100) has received Orphan Drug Designation to treat idiopathic pulmonary fibrosis (IPF). The…

Continue Reading
Man paralyzed in biking accident regains walking ability in peptide drug trial

Man paralyzed in biking accident regains walking ability in peptide drug trial

NEWYou can now listen to Fox News articles! An experimental drug could help to improve movement…

Continue Reading
The First FDA-Approved Biologic Drug to Treat Uncontrolled COPD

The First FDA-Approved Biologic Drug to Treat Uncontrolled COPD

Dupixent (dupilumab), a drug already used to treat atopic dermatitis and asthma, became the first biologic…

Continue Reading